AML blasts were also sensitive to AAL(S) (median IC50 3.1 μM; range 5.1–4.7 μM) with no significant difference between WT and FLT3-ITD patients (Figure 3G). The gene discussed is FLT3; the disease is acute myeloid leukemia.